In osteosarcoma, CASC2 expression downregulation was observed in patient tissue samples and cell lines, and low expression in tissue was associated with poor tumor differentiation, higher malignancy grade, and shortened patient survival [18]. The gene discussed is CASC2; the disease is neoplasm.